Summary Stage 2018: Lacrimal Gland/Sac

Summary Stage 2018

Notes

**Lacrimal Gland/Sac** 8000-8700, 8941, 8980, 8982, 9700-9701 C695 C695 Lacrimal gland C695 Lacrimal sac **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 69 *Lacrimal Gland Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following chapters for the listed histologies * 8710-8714, 8800-8921, 8932-8934, 8940, 8950-8975, 8981, 8983-8990, 9000-9016, 9030-9137, 9141-9175, 9181-9230, 9240-9509, 9520-9582: *Orbital Sarcoma* * 8720-8790: *Eye Other* * 8930-8931, 8991, 9020, 9180, 9231: *Soft Tissue* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* * 9510-9514: *Retinoblastoma* **Note 3:** Summary Stage is the only applicable staging system for Lacrimal Sac.

NAACCR Item

NAACCR #764
SS2018 Description
0 In situ: noninvasive, intraepithelial
1 Localized only (localized, NOS) - Confined to lacrimal gland + WITH or WITHOUT extraglandular extension into the orbital soft tissue + No periosteal or orbital bone involvement or UNKNOWN if involved
2 Regional by direct extension only - Confined to lacrimal gland + AND involvement of periosteum AND/OR periorbital bone
3 Regional lymph node(s) involved only - Cervical, NOS - Mandibular, NOS + Submandibular (submaxillary) - Parotid, NOS + Infra-auricular + Preauricular - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Adjacent structure(s), NOS + Brain + Cavernous sinus + Orbital bone + Periosteum + Pterygoid fossa + Sinuses + Superior orbital fissure + Temporal fossa - Distant lymph node(s), NOS - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) White, V.A., Finger, P.T., et al. **Lacrimal Gland Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 833-839